share_log

Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.

SEC announcement ·  Feb 14 12:53
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more